Signs Of Rem Sleep Behavior Disorder: Uncovering The Symptoms

REM sleep behaviour disorder (RBD) is a sleep disorder that causes people to physically act out their dreams while remaining asleep. The disorder can cause people to shout, scream, kick, punch, grab their bed partner, and jump out of bed. RBD can lead to accidental injury to oneself or one's bed partner, so it's important to seek treatment.

The patient acts out their dreams, potentially causing harm to themselves or others

REM sleep behaviour disorder (RBD) is a parasomnia, a sleep disorder that involves unusual and undesirable physical events or experiences that disrupt sleep. People with RBD act out their dreams, often violently, and can cause harm to themselves or their bed partner. This can include punching, kicking, jumping out of bed, or shouting. The person acting out their dreams is usually unaware of their actions and can be woken up easily.

RBD is particularly dangerous because it involves a loss of the usual temporary paralysis of the body's muscles during the REM stage of sleep. This paralysis, called muscle atonia, normally occurs during REM sleep to allow us to dream safely. Without it, people with RBD can unknowingly act out their dreams, potentially causing harm to themselves or others.

The risk of injury is high in RBD, with about 8 in 10 people experiencing sleep-related injuries. These injuries can be life-threatening and affect both the person with RBD and their bed partner. In fact, up to 90% of partners of people with RBD report sleep issues, and over 60% have experienced physical injuries.

Due to the violent nature of RBD episodes, it is important to create a safe sleeping environment. This can include removing sharp or heavy objects from the bedroom, placing pillows or padding around the bed, or even sleeping in a different room from one's partner.

RBD is also associated with neurodegenerative disorders, particularly Parkinson's disease, Lewy body dementia, and multiple system atrophy. Most people with RBD will eventually develop one of these conditions. Therefore, it is important to seek treatment and create a safe sleeping environment to prevent injuries.

The patient can recall the content of their dreams upon awakening

REM sleep behaviour disorder (RBD) is a parasomnia in which individuals act out their dreams during the REM stage of sleep. Patients with RBD can recall the content of their dreams upon awakening. This sleep disorder can cause individuals to unknowingly act out their dreams through physical movements and vocalisations during sleep. These movements can be violent and lead to injuries to themselves or others.

RBD is characterised by abnormal vocalisations, abnormal motor behaviour, and altered dream mentation. Patients may experience vivid, intense, action-filled, and violent dreams that coincide with the onset of RBD. The dreams are often frightening, such as being chased or attacked, and individuals may unknowingly enact these dreams in real life. For example, a man with RBD may dream of playing a game of football and dive from his bed to catch a pass, or he may dream of being chased and leap out of bed to run away.

Upon awakening, patients with RBD are usually alert and coherent and can recall the content of their dreams. This is a distinguishing factor from night terrors, where individuals are typically difficult to wake up and are confused when awake. The ability to recall dreams is also a differentiating factor from sleepwalking, where there is no dream reenactment and individuals are usually confused upon waking up.

The ability to recall dreams upon awakening is an important diagnostic criterion for RBD. According to the International Classification of Sleep Disorders, a diagnosis of RBD requires repeated episodes of sleep-related vocalisations and/or complex motor behaviours that correspond to the content of the dreams. Healthcare providers will conduct a thorough sleep history and may recommend a sleep study to observe and record any dream enactment behaviours.

The recall of dream content upon awakening is a key feature of RBD and helps differentiate it from other sleep disorders such as sleepwalking and night terrors. It also provides valuable information for diagnosis and treatment planning.

The patient may develop neurodegenerative diseases such as Parkinson's disease

REM sleep behavior disorder (RBD) is a parasomnia involving dream enactment behavior associated with loss of atonia during rapid eye movement (REM) sleep. RBD is strongly linked to neurodegenerative diseases, and patients with RBD will often eventually develop one of the following: Parkinson's disease, Lewy body dementia, or multiple system atrophy.

The pathophysiology of RBD is not yet fully understood, but it is thought to be caused by an interruption or disinhibition of the brainstem areas that control muscle tonicity during REM sleep. There is also a strong association between RBD and synucleinopathies, which involve aggregates of insoluble alpha-synuclein protein.

RBD can be idiopathic, secondary, or drug-induced. Idiopathic RBD is most suggestive of neurodegenerative synucleinopathies, while secondary RBD is often associated with antidepressant use, narcolepsy, or neurological disorders. Drug-induced RBD is most commonly associated with the use of antidepressants.

The diagnosis of RBD requires confirmation by an in-laboratory sleep study (polysomnography) with video recording, which helps to identify abnormal behaviors during REM sleep and exclude other sleep disorders. The treatment of RBD focuses on injury prevention and the treatment of any underlying conditions. Pharmacological treatment may also be used in severe cases, with oral medications such as melatonin or clonazepam.

The patient may experience secondary causes of RBD associated with Parkinsonism, narcolepsy, or antidepressant use

REM sleep behavior disorder (RBD) is a parasomnia characterised by a loss of normal muscle atonia during REM sleep, causing patients to physically and/or vocally act out their dreams. This can include yelling, laughing, crying, complex voluntary movements, falling out of bed, and even violent behaviours that can result in injury.

RBD is often idiopathic, but it can also be symptomatic or secondary, meaning it occurs due to an underlying cause. One such cause is antidepressant use. Antidepressants are among the most commonly prescribed medications and can trigger RBD symptoms in up to 6% of users. This connection is particularly notable in older patients.

While the reason for the link between antidepressants and RBD is unclear, several mechanisms have been proposed:

• Antidepressants may independently cause an idiopathic-like RBD disorder that is unrelated to synucleinopathy. In this case, the risk of neurodegenerative disease would be low, and there would be few signs of neurodegenerative synucleinopathy in RBD patients taking antidepressants.
• Antidepressants may not cause RBD per se, but they may augment or trigger an underlying subclinical RBD, resulting in an earlier clinical presentation. In this scenario, the risk of neurodegenerative disease would be lower than in pure idiopathic RBD, but markers of neurodegeneration would still be present.
• Antidepressants may be a proxy marker of another prodromal sign of neurodegeneration, such as depression. If this is the case, the risk of neurodegenerative disease may be higher than in idiopathic RBD, and markers of neurodegeneration would be present to the same degree or more.

In addition to antidepressant use, RBD can also be associated with Parkinsonism and narcolepsy.

Parkinsonism

RBD can precede the symptoms of Parkinson's disease or Parkinsonism by many years. The majority of people with RBD will eventually develop Parkinsonism or a related condition, such as tremor, slow movement, impaired speech, or muscle stiffness. A 2014 study found that 33% of patients with RBD had a neurodegenerative condition after five years, 76% after 10 years, and 91% after 14 years.

Narcolepsy

Narcolepsy is a chronic neurological disorder that affects the brain's ability to control sleep-wake cycles. People with narcolepsy experience excessive daytime sleepiness (EDS) and may also have fragmented sleep at night, making it difficult to stay asleep for long periods. They can also enter REM sleep much faster than usual, sometimes within 15 minutes of falling asleep.

Type 1 narcolepsy is characterised by cataplexy and excessive daytime sleepiness, while Type 2 narcolepsy typically involves excessive daytime sleepiness without cataplexy and less severe symptoms. Up to 36% of people with Type 1 narcolepsy have secondary (symptomatic) RBD.

In summary, while RBD can be idiopathic, it can also be symptomatic or secondary, associated with conditions such as Parkinsonism, narcolepsy, or the use of certain antidepressants.

The patient may require medication such as melatonin or clonazepam to manage symptoms

REM sleep behaviour disorder (RBD) is a parasomnia in which a person physically and/or vocally acts out their dreams during the rapid eye movement (REM) stage of sleep. The disorder can lead to accidental injury to the patient or their bed partner, so it is important to seek treatment. While there are no U.S. Food and Drug Administration (FDA)-approved medications specifically for RBD, studies have shown that melatonin and clonazepam can reduce symptoms in some cases.

Melatonin is a hormone that is naturally produced by the pineal gland and is essential for regulating the sleep cycle. It is considered the first-line medication for treating RBD as it rarely causes side effects. Treatment typically begins with a baseline dose, which is then increased gradually until symptoms improve. Melatonin has been shown to reduce clinical behavioural outcomes and decrease muscle tonicity during REM sleep. It also has a more favourable safety profile than clonazepam, with limited potential for drug-drug interactions. This is particularly important for elderly individuals with RBD who may be taking multiple medications.

Clonazepam is a sedative that is widely prescribed due to its anxiolytic, anticonvulsant, and hypnotic properties. It is not known exactly why clonazepam helps treat RBD, but most people with the disorder who take a low dose of the drug before sleeping have fewer or no nightmares, vocalisations, or dream enactment behaviours. However, clonazepam can cause unpleasant side effects, including daytime drowsiness, dizziness, and motor and balance impairments, especially in older adults. Therefore, it is typically only prescribed if melatonin is ineffective or not well tolerated.

In addition to medication, safety measures such as removing sharp objects from the bedroom and placing pillows between the patient and surrounding structures can help create a safer sleeping environment for individuals with RBD.

Frequently asked questions